Regeneron Announces Investor Conference Presentations

Rhea-AI Summary

Regeneron (NASDAQ: REGN) will webcast management presentations at multiple investor conferences in November–December 2025. Scheduled webcasts: Jefferies London Healthcare Conference on Nov 17, 2025 at 3:30 p.m. GMT (10:30 a.m. ET); Wolfe Research Healthcare Conference on Nov 17, 2025 at 9:20 a.m. ET; Evercore Healthcare Conference on Dec 2, 2025 at 1:20 p.m. ET; and Citi Global Healthcare Conference on Dec 3, 2025 at 10:30 a.m. ET.

Sessions can be accessed from Regeneron’s Investors & Media events page and replays and transcripts will be archived on the company website for at least 30 days.

TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025
• 7^th Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on Monday, November 17, 2025
• 8^th Annual Evercore Healthcare Conference at 1:20 p.m. ET on Tuesday, December 2, 2025
• Citi 2025 Global Healthcare Conference at 10:30 a.m. ET on Wednesday, December 3, 2025

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com

FAQ

When will Regeneron (REGN) present at the Jefferies London Healthcare Conference in 2025?

Regeneron management will present on November 17, 2025 at 3:30 p.m. GMT (10:30 a.m. ET).

How can investors watch Regeneron (REGN) presentations on November 17, 2025?

Watch live via the Investors & Media events page on Regeneron’s website at the scheduled times.

What time is Regeneron (REGN) scheduled at the Evercore Healthcare Conference?

Regeneron is scheduled for December 2, 2025 at 1:20 p.m. ET at the Evercore conference.

Will Regeneron (REGN) post replays and transcripts of the December 2025 conference webcasts?

Yes. Replays and transcripts will be archived on the company website for at least 30 days after each session.

Where is the Regeneron (REGN) Citi 2025 Global Healthcare Conference webcast and when is it?

The Citi conference webcast is on December 3, 2025 at 10:30 a.m. ET and is available from Regeneron’s investor events page.